Digestive Diseases and Sciences

, Volume 55, Issue 8, pp 2406–2411

Gallbladder Stent Placement for Prevention of Cholecystitis in Patients Receiving Covered Metal Stent for Malignant Obstructive Jaundice: A Feasibility Study

  • Sonia Gosain
  • Hugo Bonatti
  • LaVone Smith
  • Michele E. Rehan
  • Andrew Brock
  • Anshu Mahajan
  • Melissa Phillips
  • Henry C. Ho
  • Kristi Ellen
  • Vanessa M. Shami
  • Michel Kahaleh
Original Article

Abstract

Purpose

Covered self-expanding metal stents (CSEMS) have been used for palliation of malignant distal biliary strictures. Occlusion of the cystic duct by CSEMS may be complicated by cholecystitis. This potentially could be prevented by placement of a transpapillary gallbladder stent (GBS).

Patients and Methods

Between 11/2006 and 10/2007, a total of 73 patients (50 male) aged 65 ± 14 years underwent CSEMS placement for palliation of malignant obstructive jaundice. In cases where CSEMS placement caused occlusion of the cystic duct, a 7 French transpapillary pigtail gallbladder stent (GBS) was inserted to prevent cholecystitis.

Results

Of the 73 patients, 18 had a prior cholecystectomy; 34 had the CSEMS placed below the cystic duct insertion. In 19 out of the 21 patients who had a CSEMS covering the cystic duct ostium, GBS placement was attempted, which was successful in 11 individuals (58%). An attempt to access the gallbladder was complicated by wire perforation of the cystic duct in three patients; one patient requiring emergent cholecystostomy tube placement. None of the patients who underwent successful GBS placement developed cholecystitis. One GBS dislodged and was repositioned. Cholecystitis occurred in two (20%) of the ten patients without transpapillary gallbladder decompression who had a CSEMS covering the cystic duct.

Conclusions

The ideal placement of a CSEMS is below the cystic duct insertion. Should the cystic duct ostium be occluded, placement of a GBS should be considered to minimize the risk of cholecystitis.

Keywords

Gallbladder stent Cholecystitis Bile duct stricture Pancreatic cancer 

References

  1. 1.
    Michelassi F, Erroi F, Dawson PJ, et al. Experience with 647 consecutive tumors of the duodenum, ampulla, head of the pancreas, and distal common bile duct. Ann Surg. 1989;210:544–554; discussion 554–546.CrossRefPubMedGoogle Scholar
  2. 2.
    Ishii N, Suzuki S, Fujitani S, et al. A case of recurrent gallbladder cancer responding to chemotherapy with gemcitabine after endoscopic metallic biliary stent implantation. Gan To Kagaku Ryoho. 2008;35:1403–1405.PubMedGoogle Scholar
  3. 3.
    Krishnan S, Rana V, Evans DB, et al. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater. Int J Radiat Oncol Biol Phys. 2008;70:735–743.PubMedGoogle Scholar
  4. 4.
    Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction. Lancet. 1994;344:1655–1660.CrossRefPubMedGoogle Scholar
  5. 5.
    Jeurnink SM, Steyerberg EW, Hof G, van Eijck CH, Kuipers EJ, Siersema PD. Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. J Surg Oncol. 2007;96:389–396.CrossRefPubMedGoogle Scholar
  6. 6.
    Raty S, Sand J, Piironen A, Nordback I. Complications of palliative hepaticojejunostomy and gastrojejunostomy in unresectable periampullary cancer: patient- and disease-related risk factors. Hepatogastroenterology. 2006;53:133–137.PubMedGoogle Scholar
  7. 7.
    Brandabur JJ, Kozarek RA, Ball TJ, et al. Nonoperative versus operative treatment of obstructive jaundice in pancreatic cancer: cost and survival analysis. Am J Gastroenterol. 1988;83:1132–1139.PubMedGoogle Scholar
  8. 8.
    Kahaleh M, Brock A, Conaway MR, et al. Covered self-expandable metal stents in pancreatic malignancy regardless of resectability: a new concept validated by a decision analysis. Endoscopy. 2007;39:319–324.CrossRefPubMedGoogle Scholar
  9. 9.
    Raikar GV, Melin MM, Ress A, et al. Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer. Ann Surg Oncol. 1996;3:470–475.CrossRefPubMedGoogle Scholar
  10. 10.
    Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488–1492.CrossRefPubMedGoogle Scholar
  11. 11.
    Moss AC, Morris E, Mac Mathuna P. Palliative biliary stents for obstructing pancreatic carcinoma. Cochrane Database Syst Rev. 2006: CD004200.Google Scholar
  12. 12.
    Tsuyuguchi T, Takada T, Miyazaki M, et al. Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas. J Hepatobiliary Pancreat Surg. 2008;15:69–73.CrossRefPubMedGoogle Scholar
  13. 13.
    do Park H, Kim MH, Choi JS, et al. Covered versus uncovered wallstent for malignant extrahepatic biliary obstruction: a cohort comparative analysis. Clin Gastroenterol Hepatol. 2006;4:790–796.CrossRefGoogle Scholar
  14. 14.
    Yoon WJ, Lee JK, Lee KH, et al. A comparison of covered and uncovered wallstents for the management of distal malignant biliary obstruction. Gastrointest Endosc. 2006;63:996–1000.CrossRefPubMedGoogle Scholar
  15. 15.
    Isayama H, Kawabe T, Nakai Y, et al. Cholecystitis after metallic stent placement in patients with malignant distal biliary obstruction. Clin Gastroenterol Hepatol. 2006;4:1148–1153.CrossRefPubMedGoogle Scholar
  16. 16.
    Suk KT, Kim HS, Kim JW, et al. Risk factors for cholecystitis after metal stent placement in malignant biliary obstruction. Gastrointest Endosc. 2006;64:522–529.CrossRefPubMedGoogle Scholar
  17. 17.
    Kahaleh M, Tokar J, Le T, Yeaton P. Removal of self-expandable metallic wallstents. Gastrointest Endosc. 2004;60:640–644.CrossRefPubMedGoogle Scholar
  18. 18.
    Fumex F, Coumaros D, Napoleon B, et al. Similar performance but higher cholecystitis rate with covered biliary stents: results from a prospective multicenter evaluation. Endoscopy. 2006;38:787–792.CrossRefPubMedGoogle Scholar
  19. 19.
    Ogawa O, Yoshikumi H, Maruoka N, et al. Predicting the success of endoscopic transpapillary gallbladder drainage for patients with acute cholecystitis during pretreatment evaluation. Can J Gastroenterol. 2008;22:681–685.PubMedGoogle Scholar
  20. 20.
    Conway JD, Russo MW, Shrestha R. Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease. Gastrointest Endosc. 2005;61:32–36.CrossRefPubMedGoogle Scholar
  21. 21.
    Kjaer DW, Kruse A, Funch-Jensen P. Endoscopic gallbladder drainage of patients with acute cholecystitis. Endoscopy. 2007;39:304–308.CrossRefPubMedGoogle Scholar
  22. 22.
    Pannala R, Petersen BT, Gostout CJ, Topazian MD, Levy MJ, Baron TH. Endoscopic transpapillary gallbladder drainage: 10-year single center experience. Minerva Gastroenterol Dietol. 2008;54:107–113.PubMedGoogle Scholar
  23. 23.
    Saluja SS, Gulati M, Garg PK, et al. Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol. 2008;6:944–950. (e943).CrossRefPubMedGoogle Scholar
  24. 24.
    Schlenker C, Trotter JF, Shah RJ, et al. Endoscopic gallbladder stent placement for treatment of symptomatic cholelithiasis in patients with end-stage liver disease. Am J Gastroenterol. 2006;101:278–283.CrossRefPubMedGoogle Scholar
  25. 25.
    Kaassis M, Boyer J, Dumas R, et al. Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 2003;57:178–182.CrossRefPubMedGoogle Scholar
  26. 26.
    Levy MJ, Baron TH, Gostout CJ, Petersen BT, Farnell MB. Palliation of malignant extrahepatic biliary obstruction with plastic versus expandable metal stents: an evidence-based approach. Clin Gastroenterol Hepatol. 2004;2:273–285.CrossRefPubMedGoogle Scholar
  27. 27.
    Lammer J, Hausegger KA, Fluckiger F, et al. Common bile duct obstruction due to malignancy: treatment with plastic versus metal stents. Radiology. 1996;201:167–172.PubMedGoogle Scholar
  28. 28.
    Schmassmann A, von Gunten E, Knuchel J, Scheurer U, Fehr HF, Halter F. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol. 1996;91:654–659.PubMedGoogle Scholar
  29. 29.
    Yeoh KG, Zimmerman MJ, Cunningham JT, Cotton PB. Comparative costs of metal versus plastic biliary stent strategies for malignant obstructive jaundice by decision analysis. Gastrointest Endosc. 1999;49:466–471.CrossRefPubMedGoogle Scholar
  30. 30.
    Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction. Gut. 2004;53:729–734.CrossRefPubMedGoogle Scholar
  31. 31.
    Kahaleh M, Tokar J, Conaway MR, et al. Efficacy and complications of covered wallstents in malignant distal biliary obstruction. Gastrointest Endosc. 2005;61:528–533.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Sonia Gosain
    • 1
  • Hugo Bonatti
    • 2
  • LaVone Smith
    • 1
  • Michele E. Rehan
    • 1
  • Andrew Brock
    • 1
  • Anshu Mahajan
    • 1
  • Melissa Phillips
    • 2
  • Henry C. Ho
    • 1
  • Kristi Ellen
    • 1
  • Vanessa M. Shami
    • 1
  • Michel Kahaleh
    • 1
  1. 1.Digestive Health CenterUniversity of Virginia Health SystemCharlottesvilleUSA
  2. 2.Department of SurgeryUniversity of Virginia Health SystemCharlottesvilleUSA

Personalised recommendations